128 related articles for article (PubMed ID: 28237800)
1. An extract of the marine alga Alaria esculenta modulates α-synuclein folding and amyloid formation.
Giffin JC; Richards RC; Craft C; Jahan N; Leggiadro C; Chopin T; Szemerda M; MacKinnon SL; Ewart KV
Neurosci Lett; 2017 Mar; 644():87-93. PubMed ID: 28237800
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation.
Lobbens ES; Breydo L; Skamris T; Vestergaard B; Jäger AK; Jorgensen L; Uversky V; van de Weert M
Biochim Biophys Acta; 2016 Sep; 1864(9):1160-1169. PubMed ID: 27353564
[TBL] [Abstract][Full Text] [Related]
3. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
[TBL] [Abstract][Full Text] [Related]
4. In vitro evidence that an aqueous extract of Centella asiatica modulates α-synuclein aggregation dynamics.
Berrocal R; Vasudevaraju P; Indi SS; Sambasiva Rao KR; Rao KS
J Alzheimers Dis; 2014; 39(2):457-65. PubMed ID: 24284367
[TBL] [Abstract][Full Text] [Related]
5. The interaction of several herbal extracts with α-synuclein: Fibril formation and surface plasmon resonance analysis.
Honarmand S; Dabirmanesh B; Amanlou M; Khajeh K
PLoS One; 2019; 14(6):e0217801. PubMed ID: 31185031
[TBL] [Abstract][Full Text] [Related]
6. Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.
Ulrih NP; Barry CH; Fink AL
Biochim Biophys Acta; 2008 Oct; 1782(10):581-5. PubMed ID: 18692132
[TBL] [Abstract][Full Text] [Related]
7. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
Liu Y; Carver JA; Calabrese AN; Pukala TL
Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
[TBL] [Abstract][Full Text] [Related]
8. Modulating α-synuclein fibril formation using DNA tetrahedron nanostructures.
Yoo WK; Ryu BH; Kim KR; Wang Y; Le LTHL; Lee JH; Kim KK; Toth G; Ahn DR; Doohun Kim T
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):73-81. PubMed ID: 30278239
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation.
Kessler JC; Rochet JC; Lansbury PT
Biochemistry; 2003 Jan; 42(3):672-8. PubMed ID: 12534279
[TBL] [Abstract][Full Text] [Related]
10. Modification by glyceraldehyde-3-phosphate prevents amyloid transformation of alpha-synuclein.
Barinova K; Serebryakova M; Sheval E; Schmalhausen E; Muronetz V
Biochim Biophys Acta Proteins Proteom; 2019 Apr; 1867(4):396-404. PubMed ID: 30639428
[TBL] [Abstract][Full Text] [Related]
11. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway.
Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF
FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991
[TBL] [Abstract][Full Text] [Related]
12. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
[TBL] [Abstract][Full Text] [Related]
13. Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein.
Maiti NC; Apetri MM; Zagorski MG; Carey PR; Anderson VE
J Am Chem Soc; 2004 Mar; 126(8):2399-408. PubMed ID: 14982446
[TBL] [Abstract][Full Text] [Related]
14. Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study.
Alimohammadi E; Khedri M; Miri Jahromi A; Maleki R; Rezaian M
Int J Nanomedicine; 2020; 15():6887-6903. PubMed ID: 32982240
[TBL] [Abstract][Full Text] [Related]
15. Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment.
Kim HJ; Chatani E; Goto Y; Paik SR
J Microbiol Biotechnol; 2007 Dec; 17(12):2027-32. PubMed ID: 18167451
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity.
Coelho-Cerqueira E; Pinheiro AS; Follmer C
Bioorg Med Chem Lett; 2014 Jul; 24(14):3194-8. PubMed ID: 24835632
[TBL] [Abstract][Full Text] [Related]
17. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
[TBL] [Abstract][Full Text] [Related]
18. Modulating the Amyloidogenesis of α-Synuclein.
Sivanesam K; Andersen NH
Curr Neuropharmacol; 2016; 14(3):226-37. PubMed ID: 26517049
[TBL] [Abstract][Full Text] [Related]
19. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study.
Sanjeev A; Mattaparthi VSK
Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628
[TBL] [Abstract][Full Text] [Related]
20. Forcing nonamyloidogenic beta-synuclein to fibrillate.
Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
